SciGen is a rapidly growing biopharmaceutical company that markets and commercializes innovative and affordable healthcare products worldwide. We leverage our commercialization and networking capabilities to in-licenses and distribute branded pharmaceutical products and medical devices to treat endocrinological and oncological diseases, and continuously fill and improve our pipeline and product portfolio. Founded in the Asian Innovation Capital, Singapore in 1988, we currently have operations in Singapore, South Korea, Australia, China, Philippines and present commercially in all 6 continents. With the exceptional commercialization capabilities, regulatory expertise as well as international management experiences, and strategic partnerships built with industry and academic institutes, we strive to deliver hope and make a real and lasting difference to patients and their families.

Who are we?
- We believe in delivering solutions that matter to the people of today and innovating for the people of tomorrow.
- To us, it is more than a business - it is a mission.

What do we do?
- We combine a specialty pharmaceutical business with a leading biologics biotechnology engine.
- We partner to bring the best drugs we can find to the patients who need it most.

How do we do it?
- Our efforts aim to deliver better patient outcomes through better science.
- We understand that humility and service matter as it is not about us, it is about making patients’ lives better.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

SciGen Pte. Ltd.

The Manila office focuses on brand management, regulatory affairs, and sales within the diabetes and endocrinology sectors.

Manila

The Ho Chi Minh office focuses on regulatory compliance and management in the pharmaceutical and healthcare sectors.

People (5)

Jobs (0)

Other offices